STERIS rises after Jefferies upgrades its outlook on valuation and steady growth
What is behind the stock move?
Jefferies upgraded STERIS from Hold to Buy on November 13 and raised its price target from $232 to $305. Analyst David Windley sees resilient demand for healthcare supplies and services and less pressure on growth. That supports a stronger valuation case, although the target remains an analyst opinion and depends on execution.
Latest company research
STERIS rose about 4% during trading on November 13 after Jefferies upgraded the infection-prevention company to Buy.
- Jefferies raised its price target to $305 from $232 citing a more attractive valuation and easing business pressures.
- STERIS earns money from sterilization equipment, supplies and recurring services used by hospitals and life-science customers.
- The analyst highlighted resilient healthcare supplies and service demand. Repeated purchases can help sustain growth between large equipment orders.
- In its November 4 report, STERIS raised its fiscal 2027 adjusted profit outlook to $11.35–$11.55 per share; tariff refunds contributed to the increase.
- Sterilization remains the key test: the company lowered that business’s organic revenue growth outlook to 6–7% from 7–8%.
- The November 12 close was $253.44. A sustained move above the recent $257–$260 highs would strengthen the chart; losing $247–$250 would weaken it.
Watch whether sterilization demand improves and the proposed Xodus acquisition closes as planned. Slower hospital spending or integration problems could challenge the growth case.
Financials and technicals
Charts through Nov 12, 2026. The session move above may reflect later news.
Technical setup and risks
November 12 charts show a strong advance above the 20-day and 50-day averages. Recent highs cluster near $257–$260; November 5–9 lows support a $247–$250 zone. These are conditional levels, not guarantees. Jefferies’s target is an opinion rather than company guidance.
AI-assisted research with source and calculation checks. Prices may be delayed. Technical charts use the stated completed session, which can precede the quoted intraday move. Educational information; investing involves risk.